Clinical trials
Recruiting Phase 2 Endometrial Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 14 |
| 2025 | 13 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| National Cancer Institute (NCI) | 3 |
| Yonsei University | 3 |
| Fudan University | 2 |
| Peking University People's Hospital | 2 |
| 3D Medicines (Sichuan) Co., Ltd. | 1 |
| Aadi Bioscience, Inc. | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Acrivon Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 52 |
| Ovarian Neoplasms | 13 |
| Uterine Cervical Neoplasms | 11 |
| Breast Neoplasms | 7 |
| Colorectal Neoplasms | 6 |
| Fallopian Tube Neoplasms | 6 |
| Pancreatic Neoplasms | 6 |
| Neoplasms | 5 |
| Stomach Neoplasms | 5 |
| Endometrial Hyperplasia | 4 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.